FDA removes clinical hold on study of Multikine for head and neck cancer - Healio

TheStreet.com

FDA removes clinical hold on study of Multikine for head and neck cancer Healio The FDA removed the clinical hold from a phase 3 study designed to evaluate leukocyte interleukin injection for the treatment of newly diagnosed head and neck cancer, according to the agent's manufacturer. All clinical trial activities under the ... US FDA Removes Clinical Hold on CEL-SCI's Phase 3 Head & Neck Cancer TrialBusiness Wire (press release) Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move ForwardTheStreet.com FDA gives Ergomed's partner green light to resume phase III cancer studyProactive Investors UK London South East (registration) (blog) -CNA Finance (press release) all 8 news articles »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wJ3Ram
via IFTTT